H.C. Wainwright Initiates Rani Therapeutics (RANI) with Buy and $11 PT on RaniPill Potential
Rani Therapeutics Holdings Inc. (NASDAQ:RANI) is one of the hot stocks to buy with huge upside potential. On October 21, H.C.
Rani Therapeutics Holdings Inc. (RANI)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 8,500,000 | $6,245,800 | 0.07% | |
| 2. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 8,500,000 | $6,245,800 | 0.61% | |
| 3. | Longaeva Partners Peter Goodwin | 2,329,459 | $1,711,686 | +11% | 0.06% |
| 4. | Siren L.L.C. Raymond Debbane | 2,000,000 | $1,469,600 | 0.04% | |
| 5. | 683 Capital Partners Ari Zweiman | 487,168 | $357,971 | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.61 | 2,083,334 | $1,260,417.07 | 2,083,334 | 2025-10-23 | Filing | |
| $1.67 | 17,960 | $29,993.20 | 17,960 | 2024-12-13 | Filing | |
| $1.94 | 10,296 | $19,974.24 | 494,751 | 2024-12-09 | Filing | |
| $2.01 | 5,265,165 | $10,582,981.65 | 12,131,554 | 2023-11-24 | Filing | |
| $2.27 | 10,000 | $22,700.00 | 484,455 | 2023-12-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.77 | 4,000,000 | $11,074,000.00 | 2,379,194 | 2025-10-21 | Filing | |
| $2.41 | 1,923,000 | $4,637,314.50 | 6,379,194 | 2025-10-20 | Filing | |
| $3.26 | 523,738 | $1,705,395.68 | 8,302,194 | 2024-10-15 | Filing | |
| $2.55 | 3,305,622 | $8,436,277.91 | 8,825,932 | 2024-10-15 | Filing | |
| $2.01 | 5,265,165 | $10,582,981.65 | 8,400 | 2023-11-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,500,000 | $4,776,200 | 0.53% | |
| 2. | 4,622,567 | $3,397,587 | 0% | |
| 3. | 3,667,585 | $2,694,941 | 5.11% | |
| 4. | 3,011,800 | $2,213,071 | 0% | |
| 5. | 1,202,500 | $877,825 | 0% |
News See All
12 Hot Stocks to Buy with Huge Upside Potential
On October 22, Vios Advisors’ Michael Bapis and BNY’s Alicia Levine joined CNBC's 'Closing Bell' to discuss the latest news affecting markets.
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2024 Earnings Call Transcript
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2024 Earnings Call Transcript March 31, 2025Rani Therapeutics Holdings, Inc. misses on earnings expectations.
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript
Rani Therapeutics Holdings, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-0.33.
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2022 Earnings Call Transcript
Operator: Hello, and welcome to Rani Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. At this time, all participants are a in a listen-only mode.
8 Best Stocks to Buy According to Billionaire Marc Lasry
In this article, we will take a look at the 8 Best Stocks to Buy According to Billionaire Marc Lasry.
Hedge Fund Resource Center